Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 23.27%36.59B | 23.22%24.12B | 25.60%12.42B | 19.56%42.35B | 12.14%29.69B | 7.93%19.58B | -2.44%9.89B | -1.68%35.42B | 2.71%26.47B | 5.48%18.14B |
| Refunds of taxes and levies | 21.80%1.31B | 17.50%853.62M | -5.50%425.1M | 11.66%1.37B | 23.50%1.08B | 29.11%726.52M | 71.77%449.86M | -18.24%1.22B | -22.72%872M | -21.90%562.69M |
| Cash received relating to other operating activities | 2.98%287.33M | -18.15%193.63M | -25.70%154.69M | -42.66%373M | -49.65%279.02M | -47.88%236.58M | -40.60%208.19M | -3.65%650.52M | -12.04%554.16M | -5.62%453.92M |
| Cash inflows from operating activities | 23.03%38.19B | 22.54%25.17B | 23.26%13B | 18.22%44.09B | 11.27%31.04B | 7.23%20.54B | -1.87%10.55B | -2.36%37.29B | 1.33%27.9B | 4.12%19.16B |
| Goods services cash paid | 23.79%27.08B | 29.75%17.78B | 34.79%9.32B | 27.48%29.48B | 24.38%21.88B | 20.34%13.71B | 14.03%6.91B | -6.48%23.13B | -4.35%17.59B | -6.12%11.39B |
| Staff behalf paid | 20.50%7.15B | 18.63%4.58B | 17.76%2.23B | 17.96%8.03B | 21.13%5.93B | 23.46%3.86B | 20.75%1.89B | -6.47%6.8B | -9.68%4.9B | -11.80%3.13B |
| All taxes paid | -14.38%1.25B | -9.92%885.08M | -8.89%483.92M | 24.16%1.98B | 36.13%1.46B | 27.58%982.53M | 30.60%531.16M | 8.92%1.59B | 5.86%1.07B | 17.95%770.15M |
| Cash paid relating to other operating activities | 22.78%416.4M | 10.12%245.46M | 14.62%153.05M | 22.41%582.86M | 2.90%339.16M | 10.31%222.9M | -16.30%133.53M | -21.27%476.17M | -7.96%329.59M | 0.75%202.07M |
| Cash outflows from operating activities | 21.23%35.9B | 25.15%23.5B | 28.65%12.19B | 25.21%40.07B | 23.95%29.61B | 21.20%18.78B | 15.55%9.47B | -6.08%32B | -5.14%23.89B | -6.30%15.49B |
| Net cash flows from operating activities | 60.19%2.3B | -5.23%1.67B | -24.24%813.87M | -24.06%4.02B | -64.26%1.43B | -51.81%1.77B | -57.87%1.07B | 28.38%5.3B | 70.67%4.01B | 96.62%3.66B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 2,920.04%120.8M | ---- | ---- | -87.12%31.67M | -97.82%4M | -96.70%4M | ---- | --245.91M | --183.57M | --121.22M |
| Cash received from returns on investments | 157.71%37.11M | 145.20%21.36M | 295.40%13.15M | -81.19%12.81M | -74.23%14.4M | -79.22%8.71M | -32.85%3.33M | 94.37%68.09M | 3,214.53%55.87M | 13.71%41.93M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,819.66%17.18M | 1,914.90%15.58M | -32.08%106.76K | -97.51%2.01M | -98.82%894.98K | -98.78%773.25K | -99.62%157.18K | 945.89%80.76M | 1,389.32%76.05M | 3,079.36%63.25M |
| Cash received relating to other investing activities | 6.28%128M | -12.47%77.63M | ---- | -90.17%211.94M | -92.62%120.44M | -92.24%88.69M | -99.36%5M | 119.66%2.16B | 169.16%1.63B | 90.38%1.14B |
| Cash inflows from investing activities | 116.91%303.09M | 12.13%114.58M | 56.27%13.26M | -89.87%258.42M | -92.82%139.73M | -92.53%102.18M | -98.97%8.48M | 120.23%2.55B | 217.65%1.95B | 114.24%1.37B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 39.01%3.33B | 44.05%2.29B | 41.22%1.06B | 58.75%3.62B | 58.85%2.39B | 40.21%1.59B | 13.14%750.72M | 2.88%2.28B | -12.57%1.51B | 2.07%1.13B |
| Cash paid to acquire investments | 255.61%90.14M | ---- | ---- | -58.45%95.12M | -89.09%25.35M | -88.84%25.37M | --2.61M | 74.74%228.9M | 102.08%232.39M | 139.28%227.32M |
| Net cash paid to acquire subsidiaries and other business units | --320M | ---- | ---- | ---- | ---- | ---- | ---- | 26.68%4.81M | ---- | ---- |
| Cash paid relating to other investing activities | 1,204.77%3.17B | 555.41%1.66B | 572.80%757.27M | -86.53%286.65M | -81.99%243.07M | -82.99%253.83M | -86.07%112.55M | 2.65%2.13B | 31.52%1.35B | 78.35%1.49B |
| Cash outflows from investing activities | 159.56%6.91B | 111.49%3.96B | 109.89%1.82B | -13.78%4B | -13.82%2.66B | -34.46%1.87B | -41.16%865.89M | 4.92%4.64B | 7.68%3.09B | 39.42%2.85B |
| Net cash flows from investing activities | -161.92%-6.61B | -117.23%-3.84B | -110.42%-1.8B | -78.89%-3.75B | -120.89%-2.52B | -19.04%-1.77B | -32.39%-857.4M | 35.94%-2.09B | 49.38%-1.14B | -5.48%-1.49B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | -85.25%2.95M | -85.25%2.95M | -85.25%2.95M | -66.09%20M | -60.76%20M | -19.92%20M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | -85.25%2.95M | -85.25%2.95M | -85.25%2.95M | -66.09%20M | -60.76%20M | -19.92%20M |
| Cash from bonds issue | ---- | ---- | ---- | --2.12B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 17.15%6.84B | -6.80%3.93B | -41.12%1.7B | -12.74%6.85B | -14.01%5.84B | 14.85%4.22B | 74.36%2.89B | 12.44%7.85B | 10.26%6.79B | 3.42%3.67B |
| Cash received relating to other financing activities | --170M | --170M | ---- | 13.58%110.03M | ---- | ---- | ---- | -51.81%96.87M | ---- | 155.20%49.43M |
| Cash inflows from financing activities | 20.01%7.01B | -2.83%4.1B | -41.18%1.7B | 13.99%9.08B | -14.22%5.84B | 12.80%4.22B | 67.44%2.89B | 10.02%7.96B | 9.58%6.81B | 4.08%3.74B |
| Borrowing repayment | 7.42%4.04B | -12.17%2.31B | -40.13%1.14B | -38.20%5.31B | -38.43%3.76B | -35.34%2.63B | 31.36%1.91B | 15.99%8.59B | 18.87%6.11B | 31.99%4.06B |
| Dividend interest payment | -20.23%311.62M | -24.35%253.56M | -3.66%55.64M | -66.55%457.19M | -64.14%390.65M | 101.11%335.15M | -37.65%57.76M | 365.27%1.37B | 399.44%1.09B | 27.52%166.65M |
| -Including:Cash payments for dividends or profit to minority shareholders | -13.71%2.61M | --2.61M | ---- | 24.46%3.03M | 24.46%3.03M | ---- | ---- | -19.65%2.43M | -19.65%2.43M | ---- |
| Cash payments relating to other financing activities | 130.12%701.9M | 148.71%621.21M | 151.73%238.71M | -39.40%559.96M | -63.54%305.01M | -51.27%249.78M | -74.80%94.83M | 32.46%924.08M | 31.35%836.65M | 46.95%512.61M |
| Cash outflows from financing activities | 13.39%5.05B | -0.93%3.18B | -30.26%1.44B | -41.87%6.33B | -44.53%4.46B | -32.27%3.21B | 7.22%2.06B | 29.58%10.88B | 34.05%8.04B | 33.29%4.74B |
| Net cash flows from financing activities | 41.38%1.95B | -8.91%917.95M | -68.18%264.61M | 194.35%2.75B | 212.14%1.38B | 200.61%1.01B | 529.22%831.63M | -151.79%-2.92B | -671.34%-1.23B | -2,846.26%-1B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -126.95%-16.33M | -77.20%14.01M | -193.67%-13.89M | 12.76%107.8M | -51.95%60.6M | -7.95%61.47M | 147.12%14.83M | 73.78%95.6M | 30.80%126.12M | 68.94%66.77M |
| Net increase in cash and cash equivalents | -773.44%-2.37B | -215.95%-1.24B | -169.56%-739.57M | 725.20%3.14B | -80.02%352.51M | -14.24%1.07B | -36.60%1.06B | 253.90%380.06M | 333.88%1.76B | 134.18%1.24B |
| Add:Begin period cash and cash equivalents | 108.16%6.04B | 108.16%6.04B | 108.16%6.04B | 15.09%2.9B | 15.22%2.9B | 15.22%2.9B | 15.22%2.9B | -8.93%2.52B | -8.93%2.52B | -8.93%2.52B |
| End period cash equivalent | 12.64%3.67B | 21.06%4.8B | 33.67%5.3B | 108.23%6.03B | -24.02%3.25B | 5.49%3.97B | -5.49%3.96B | 15.09%2.9B | 35.03%4.28B | 14.12%3.76B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.